CLASS II Device recall · Reported 8 Jun 2016 · FDA Enforcement Report

Novocastr Liquid Mouse Monoclonal Antibody Renal Cell recalled

Leica Microsystems is recalling Novocastr Liquid Mouse Monoclonal Antibody Renal Cell Carcinoma Marker (RCC) is, distributed in 12 states. The recall was initiated on 5 Apr 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes1ml size Novocastr Liquid Mouse Monoclonal Antibody Renal Cell Carcinoma Marker (RCC) with lot numbers 6036120, 6032345 and 6023543.
Quantity recalled270 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1876-2016
FDA event ID
73802
Recalling firm
Leica Microsystems, Buffalo Grove, IL
Classification
Class II
Status
Terminated
Recall initiated
5 Apr 2016
FDA classified
1 Jun 2016
Reported
8 Jun 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

5 Apr 2016Recall initiated by company
1 Jun 2016Classified by FDA+57 days
8 Jun 2016Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Testing of retained units indicated that Lot numbers of CDX2 and RCC indicated are not stable up to the expiry date on the product labeling.

Product as listed by the FDA

Novocastr Liquid Mouse Monoclonal Antibody Renal Cell Carcinoma Marker (RCC) is recommended for use as part of a panel of antibodies in the definition of tumors of proximal nephrogenic differentiation.

Where it was distributed

Distributed in the following states AR, CA, CT, FL, ID, IL, IN, MT, OH, PA, TN and TX, and in Canada.

ArkansasCaliforniaConnecticutFloridaIdahoIllinoisIndianaMontanaOhioPennsylvaniaTennesseeTexas

Questions about this recall

Why was it recalled?

Testing of retained units indicated that Lot numbers of CDX2 and RCC indicated are not stable up to the expiry date on the product labeling.

Which lots are affected?

1ml size Novocastr Liquid Mouse Monoclonal Antibody Renal Cell Carcinoma Marker (RCC) with lot numbers 6036120, 6032345 and 6023543.

Where was it sold?

Distributed in the following states AR, CA, CT, FL, ID, IL, IN, MT, OH, PA, TN and TX, and in Canada.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 73802

This product is part of a recall event; the main page for the event is Novocastr Liquid Mouse Monoclonal Antibody CDX2 recalled.

ReportedClassRecallCompanyReasonWhere
CLASS IINovocastr Liquid Mouse Monoclonal Antibody CDX2 recalledLeica MicrosystemsForeign Material12 states

More recalls from Leica Microsystems

All 40

Other Other Medical Devices recalls

All 13,884